×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IKT – inhibikase therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IKT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
08:00 am
ikt
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension
Low
Report
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension
4/3
02:10 pm
ikt
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
4/3
02:01 pm
ikt
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/26
04:01 pm
ikt
Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity
Medium
Report
Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity
3/5
07:56 am
ikt
Inhibikase Therapeutics (IKT) was upgraded by LADENBURG THALM/SH SH to "strong-buy".
Medium
Report
Inhibikase Therapeutics (IKT) was upgraded by LADENBURG THALM/SH SH to "strong-buy".
3/4
08:00 am
ikt
Inhibikase Therapeutics (IKT) is now covered by LADENBURG THALM/SH SH. They set a "buy" rating and a $4.00 price target on the stock.
Medium
Report
Inhibikase Therapeutics (IKT) is now covered by LADENBURG THALM/SH SH. They set a "buy" rating and a $4.00 price target on the stock.
2/25
06:24 am
ikt
Inhibikase Therapeutics (IKT) was upgraded by Lifesci Capital to "strong-buy".
Medium
Report
Inhibikase Therapeutics (IKT) was upgraded by Lifesci Capital to "strong-buy".
1/24
05:08 am
ikt
Inhibikase Therapeutics (NASDAQ:IKT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Inhibikase Therapeutics (NASDAQ:IKT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/7
08:09 am
ikt
Form 8-K Inhibikase Therapeutics, For: Apr 07
Low
Report
Form 8-K Inhibikase Therapeutics, For: Apr 07
3/26
05:10 pm
ikt
Form S-8 Inhibikase Therapeutics,
Low
Report
Form S-8 Inhibikase Therapeutics,
3/26
04:33 pm
ikt
Form 10-K Inhibikase Therapeutics, For: Dec 31
Low
Report
Form 10-K Inhibikase Therapeutics, For: Dec 31
3/26
04:22 pm
ikt
Form 8-K Inhibikase Therapeutics, For: Mar 26
Low
Report
Form 8-K Inhibikase Therapeutics, For: Mar 26
2/24
08:54 pm
ikt
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher
Medium
Report
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Cabell Christopher
2/24
08:54 pm
ikt
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent
Medium
Report
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Aurentz Vincent
2/24
08:49 pm
ikt
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Munshi Amit
Medium
Report
Form 4 Inhibikase Therapeutics, For: Feb 21 Filed by: Munshi Amit
2/17
06:22 pm
ikt
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: ADAR1 Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: ADAR1 Capital Management, LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: